Nick Dand, Philip E Stuart, John Bowes, David Ellinghaus, Joanne Nititham, Jake R Saklatvala, Maris Teder-Laving, Laurent F Thomas, Tanel Traks, Steffen Uebe, Gunter Assmann, David Baudry, Frank Behrens, Allison C Billi, Matthew A Brown, Harald Burkhardt, Francesca Capon, Raymond Chung, Charles J Curtis, Michael Duckworth, Eva Ellinghaus, Oliver FitzGerald, Sascha Gerdes, Christopher E M Griffiths, Susanne Gulliver, Philip Helliwell, Pauline Ho, Per Hoffmann, Oddgeir L Holmen, Zhi-Ming Huang, Kristian Hveem, Deepak Jadon, Michaela Köhm, Cornelia Kraus, Céline Lamacchia, Sang Hyuck Lee, Feiyang Ma, Satveer K Mahil, Neil McHugh, Ross McManus, Ellen H Modalsli, Michael J Nissen, Markus Nöthen, Vinzenz Oji, Jorge R Oksenberg, Matthew T Patrick, Bethany E Perez-White, Andreas Ramming, Jürgen Rech, Cheryl Rosen, Mrinal K Sarkar, Georg Schett, Börge Schmidt, Trilokraj Tejasvi, Heiko Traupe, John J Voorhees, Eike Matthias Wacker, Richard B Warren, Rachael Wasikowski, Stephan Weidinger, Xiaoquan Wen, Zhaolin Zhang, Anne Barton, Vinod Chandran, Tõnu Esko, John Foerster, Andre Franke, Dafna D Gladman, Johann E Gudjonsson, Wayne Gulliver, Ulrike Hüffmeier, Külli Kingo, Sulev Kõks, Wilson Liao, Mari Løset, Reedik Mägi, Rajan P Nair, Proton Rahman, André Reis, Catherine H Smith, Paola Di Meglio, Jonathan N Barker, Lam C Tsoi, Michael A Simpson, James T Elder
Psoriasis is a common, debilitating immune-mediated skin disease. Genetic studies have identified biological mechanisms of psoriasis risk, including those targeted by effective therapies. However, the genetic liability to psoriasis is not fully explained by variation at robustly identified risk loci. To move towards a saturation map of psoriasis susceptibility we meta-analysed 18 GWAS comprising 36,466 cases and 458,078 controls and identified 109 distinct psoriasis susceptibility loci, including 45 that have not been previously reported...
October 5, 2023: medRxiv